Industries
|
Companies
|
Filings
|
News
|
CaseLaw
|
Annual Reports
|
UK
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 6-K/A SEC Filings
Report of foreign issuer [Rules 13a-16 and 15d-16]:
[Amend]
NYMOX PHARMACEUTICAL CORP, 6-K/A, 2000-05-19
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission